In a Clinical Study, Patients Report Significant Reduction in Dry Eye Symptoms in Just 30 Days of Usage DUBLIN, Oct. 21, 2015 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical ...
MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.
All Optive products have the patented osmoprotectant formula comprised of three solutes: glycerin, I-carnitine, and erythritol. Allergan announced the launch of Refresh Optive Mega-3, a new supplement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results